Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Cystectomy
100%
Bladder Cancer
86%
Transitional Cell Carcinoma
43%
Bladder
39%
Non Muscle Invasive Bladder Cancer
34%
Diseases
32%
Malignant Neoplasm
31%
Recurrent Disease
23%
Overall Survival
20%
Muscle Invasive Bladder Cancer
19%
Tumor
17%
Health Care Cost
14%
Retroperitoneal Lymph Node Dissection
14%
Neoadjuvant Chemotherapy
13%
Lymph Node
13%
Hazard Ratio
13%
Neoplasm
12%
Clinical Trial
12%
Bladder Tumor
12%
Mycobacterium Bovis BCG
12%
Systematic Review
10%
Cancer Screening
9%
Meta-Analysis
9%
Tumor Marker
9%
Risk Stratification
9%
Cystoscopy
9%
Lymph Node Metastasis
8%
Specific Mortality
8%
Cytotechnology
8%
Urinary System
8%
Randomized Controlled Trial
7%
Lymphovascular Invasion
7%
Chemotherapy
7%
Cancer Specific Survival
7%
Hematuria
7%
Prostatectomy
7%
Intravesical Drug Administration
7%
Transurethral Resection
7%
Randomized Clinical Trials
7%
Prostate Cancer
6%
Chemoradiation Therapy
6%
Surgical Margin
6%
Adjuvant Chemotherapy
6%
Kidney Tumour
6%
Carcinoma in Situ
6%
High Risk Population
6%
Biological Marker
5%
Partial Nephrectomy
5%
Quality of Life
5%
Body Mass Index
5%
Immunology and Microbiology
Muscle
11%
Natural Killer Cell
11%
T Cell
10%
Mycobacterium Bovis BCG
9%
Immunotherapy
7%
Sirolimus
5%
Cytokine
5%